4.4 Article

Gene of the month: Interleukin 6 (IL-6)

Journal

JOURNAL OF CLINICAL PATHOLOGY
Volume 67, Issue 11, Pages 932-937

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jclinpath-2014-202493

Keywords

-

Categories

Ask authors/readers for more resources

The Interleukin 6 (IL-6) gene encodes the classic proinflammatory cytokine IL-6. It is also known as interferon-beta 2 (IFN-beta 2), B cell stimulatory factor-2 and hybridoma/plasmacytoma growth factor. IL-6 is a multifunctional cytokine with a central role in many physiological inflammatory and immunological processes. Due to its major role in initiation as well as resolving inflammation, deregulation of IL-6 is a mainstay of chronic inflammatory and autoimmune diseases. Additionally, IL-6 has been shown to be implicated in pathogenesis of many human malignancies. Thus, a better understanding of IL-6 and its role in various pathological conditions could enable the development of strategies to use it as a therapeutic target. This short review focuses on the structure, regulation and biological activities of IL-6. In addition we discuss the role of IL-6 in diseases with inflammatory background and cancer and also the therapeutic applications of anti-IL-6 agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease

Matthew K. Boag, Angus Roberts, Vladimir N. Uversky, Linlin Ma, Des R. Richardson, Dean L. Pountney

Summary: A major hallmark of Parkinson's disease is the destruction of dopaminergic neurons in the substantia nigra pars compacta. This destruction is preceded by the formation of Lewy bodies, composed of alpha-synuclein aggregates. The accumulation of alpha-synuclein, iron, and mitochondrial dysfunction affects the nigral neurons. The mechanisms underlying iron accumulation are not well understood. This review explores the relationship between iron regulation and alpha-synuclein and discusses the potential therapeutic targets in the context of Parkinson's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy

Amir Ajoolabady, Yaguang Bi, David J. McClements, Gregory Y. H. Lip, Des R. Richardson, Russel J. Reiter, Daniel J. Klionsky, Jun Ren

Summary: Atherosclerosis is a chronic proinflammatory anomaly that can lead to various cardiovascular diseases. Pharmacotherapies and adjuvants such as melatonin have shown promise in alleviating inflammation and improving the condition of the disease.

PHARMACOLOGICAL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Ascorbate-and iron-driven redox activity of Dp44mT and Emodin facilitates peroxidation of micelles and bicelles

O. Yu. Selyutina, P. A. Kononova, V. E. Koshman, E. A. Shelepova, M. Gholam Azad, R. Afroz, M. Dharmasivam, Paul V. Bernhardt, N. E. Polyakov, D. R. Richardson

Summary: Ascorbate-driven redox cycling enhances the anti-proliferative activity of Dp44mT and Emodin.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2022)

Article Chemistry, Medicinal

Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia

D. R. Richardson, M. Gholam Azad, R. Afroz, V Richardson, M. Dharmasivam

Summary: This article discusses the development of compounds that target the bidirectional oncogenic signaling between pancreatic cancer cells and pancreatic stellate cells. It also explores the discovery of additional pathways involved in this signaling and highlights the therapeutic opportunity presented by suppressing bidirectional signaling between cell types.

FUTURE MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Meeting the Challenge 2: Identification of Potential Chemical Probes for Parkinson's Disease from Ligusticum chuanxiong Hort Using Cytological Profiling

William Gang Miao, Thanh Nguyen, Jamila Iqbal, Gregory K. Pierens, Linlin Ma, Des R. Richardson, Stephen A. Wood, George D. Mellick, Ronald J. Quinn, Yunjiang Feng

Summary: This study evaluated the effects of natural compounds from Ligusticum chuanxiong on Parkinson's Disease (PD) cells, and found that 34 compounds strongly affected the staining of multiple cellular organelles, which are closely related to the pathogenesis of PD. The results helped rationalize the traditional use of Ligusticum chuanxiong in PD treatment, and these compounds can serve as chemical probes to study the molecular pathways of PD.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Medicine, Research & Experimental

Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells

Tereza Brogyanyi, Robert Kaplanek, Zdenek Kejik, Bozena Hosnedlova, Veronika Antonyova, Nikita Abramenko, Katerina Vesela, Pavel Martasek, Martin Vokurka, Des R. Richardson, Milan Jakubek

Summary: This study tested novel iron chelators for their cytotoxicity against pancreatic cancer cells, showing high toxicity and selectivity. The mechanism of action of the chelators may be associated with mitophagy induction.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Editorial Material Biochemistry & Molecular Biology

Glutathione-S-Transferases as Potential Targets for Modulation of Nitric Oxide-Mediated Vasodilation

Tiffany M. Russell, Des R. Richardson

Summary: GSTs are versatile proteins that play important roles in detoxification and cellular nitric oxide metabolism. They have the ability to convert organic nitrates into nitric oxide, thereby regulating vasodilation. GSTs are also considered suitable targets for pharmaceutical development, particularly in the field of anti-cancer drugs.

BIOMOLECULES (2022)

Article Chemistry, Medicinal

Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel Stealth Zinc(II) Complex?

Mahendiran Dharmasivam, Busra Kaya, Tharushi Wijesinghe, Mahan Gholam Azad, Miguel A. Gonzalvez, Mohammad Hussaini, Jason Chekmarev, Paul Bernhardt, Des R. Richardson

Summary: A novel and selective antitumor agent, 3-thiosemicarbazone (PPP44mT), and its analogues with distinctive properties were synthesized and characterized. The inclusion of a styrene moiety prevented the oxidation of oxy-myoglobin or oxy-hemoglobin, which is different from other potent thiosemicarbazones such as DpC or Dp44mT. PPP44mT and its Cu(II) complexes exhibited immediate cytotoxicity against SK-N-MC tumor cells, while [Zn(PPP44mT)2] showed delayed antiproliferative efficacy and superior inhibition of cyclin D1 expression compared to DpC or Dp44mT.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

The good Samaritan glutathione-S-transferase P1: An evolving relationship in nitric oxide metabolism mediated by the direct interactions between multiple effector molecules

Tiffany M. Russell, Des R. Richardson

Summary: Glutathione-S-transferases (GSTs) are isozymes that play important roles in both detoxification and redox stress suppression by conjugating glutathione (GSH) to xenobiotics and interacting with cytotoxic nitric oxide (NO). The interactions between NO and GSTs involve binding and storage of NO as dinitrosyl-dithiol iron complexes (DNICs). GSTP1 can inhibit inducible nitric oxide synthase (iNOS) and suppress c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappa B) pathways, leading to decreased apoptosis and modulating NO-mediated ROS generation. These studies highlight the innovative role of GSTs in NO metabolism and their interactions with multiple effector proteins.

REDOX BIOLOGY (2023)

Review Biochemistry & Molecular Biology

The role of the NDRG1 in the pathogenesis and treatment of breast cancer

Xiao Zhao, Des R. Richardson

Summary: Breast cancer is the leading cause of cancer death in women, and there are different clinical subtypes based on hormone receptor and HER2 status. Targeted therapies exist for ER-α positive and HER2 overexpressing tumors, but resistance and metastasis remain problems, while TNBC lacks suitable targets.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2023)

Review Pharmacology & Pharmacy

The Myc Family and the Metastasis Suppressor NDRG1 Targeting Key Molecular Interactions with Innovative Therapeutics

Zhao Deng, Des R. Richardson

Summary: This review explores the interactions between Myc proteins and other molecules, focusing on the relationship between N-Myc and NDRG1 and potential therapeutic interventions. These findings provide important insights into the understanding and treatment of neuroblastoma.

PHARMACOLOGICAL REVIEWS (2023)

Review Pharmacology & Pharmacy

Potassium Channels in Parkinson's Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment

Xiaoyi Chen, Yunjiang Feng, Ronald J. Quinn, Dean L. Pountney, Des R. Richardson, George D. Mellick, Linlin Ma

Summary: Parkinson's disease is a neurode-generative disorder caused by the loss of dopaminergic neurons in the midbrain, leading to motor symptoms. Understanding the biological targets and pathways involved in the disease is crucial for developing effective treatments. Ion channels, particularly potassium channels, play important roles in neuronal function and neuroinflammation, making them potential therapeutic targets. This review discusses the role of specific potassium channel subfamilies in Parkinson's disease pathogenesis and their potential as targets for neuroprotective drugs.

PHARMACOLOGICAL REVIEWS (2023)

Article Pharmacology & Pharmacy

Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer

Faten Shehadeh-Tout, Heloisa H. Milioli, Suraya Roslan, Patric J. Jansson, Mahendiran Dharmasivam, Dinny Graham, Robin Anderson, Tharushi Wijesinghe, Mahan Gholam Azad, Des R. Richardson, Zaklina Kovacevic

Summary: This study investigates a new class of anti-cancer agents for the treatment of ER-positive breast cancer. These agents inhibit multiple growth factor receptors and down-stream signaling, leading to decreased expression of hormone receptors and key resistance pathways. In vivo experiments demonstrate that these agents effectively inhibit ER-positive breast cancer growth. This represents an innovative non-hormonal, multi-modal therapeutic approach.

PHARMACOLOGICAL RESEARCH (2023)

Article Chemistry, Multidisciplinary

Differential transmetallation of complexes of the anti-cancer thiosemicarbazone, Dp4e4mT: effects on anti-proliferative efficacy, redox activity, oxy-myoglobin and oxy-hemoglobin oxidation

Mahendiran Dharmasivam, Busra Kaya, Tharushi P. Wijesinghe, Vera Richardson, Jeffrey R. Harmer, Miguel A. Gonzalvez, William Lewis, Mahan Gholam Azad, Paul V. Bernhardt, Des R. Richardson

Summary: This study investigates the synthesis and characterization of metal complexes of the Dp4e4mT analog, revealing their distinct effects and off-target activities in cancer treatment, with a key role played by differential transmetallation.

CHEMICAL SCIENCE (2023)

Article Chemistry, Medicinal

Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia

D. R. Richardson, M. Gholam Azad, R. Afroz, V Richardson, M. Dharmasivam

Summary: This article discusses the development of a therapeutic opportunity to overcome the development of dense stroma in pancreatic cancer by suppressing bidirectional signaling between cells.

FUTURE MEDICINAL CHEMISTRY (2022)

No Data Available